RegentAtlantic Capital’s Medicines Co MDCO Stock Holding History

RegentAtlantic Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,519	Closed	-$384K	–	484
2019 Q4	$384K	Sell	4,519 -95	-2%	-$6.33K	0.02%	345
2019 Q3	$231K	Buy	+4,614	New	+$184K	0.02%	403
2015 Q1	–	Sell	-672	Closed	-$18.6K	–	1072
2014 Q4	$18.6K	Buy	+672	New	+$16.6K	﹤0.01%	776

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

RegentAtlantic Capital's MDCO Position: Q1 2020 in Review

RegentAtlantic Capital sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 4,519 shares — an estimated $384K sold.

RegentAtlantic Capital first reported a position in MDCO in Q4 2014 and held it in 3 quarters. The position peaked at $384K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

RegentAtlantic Capital reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
RegentAtlantic Capital sold 4,519 Medicines Co shares in Q1 2020, an estimated $384K.
RegentAtlantic Capital first reported a position in Medicines Co in Q4 2014 and held it in 3 quarters.
RegentAtlantic Capital's Medicines Co position peaked at $384K in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on RegentAtlantic Capital's 13F filing for Q1 2020, filed 14 May 2020.